| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 269,743 | 290,401 | 299,674 | 379,980 | | Cost of Revenue | 178,398 | 194,044 | 204,594 | 248,088 | | | Gross Profit | 91,345 | 96,357 | 95,080 | 131,892 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 60,362 | 65,174 | 73,997 | 76,218 | | Non Recurring | (20,326) | 43,644 | 3,876 | 26,553 | | Others | 4,700 | 5,358 | 5,209 | 4,457 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 46,609 | (17,819) | 11,998 | 24,664 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (10,681) | (31,946) | 12,270 | (11,701) | | Earnings Before Interest And Taxes | 35,928 | (49,765) | 24,268 | 12,963 | | Interest Expense |
-
| (22,139) | 22,139 |
-
| | Income Before Tax | 35,928 | (27,626) | 2,129 | 12,963 | | Income Tax Expense | 9,289 | (10,028) | (1,105) | 1,370 | | Minority Interest | 4 | (36) | 10 | 5 | | | | Net Income From Continuing Ops | 26,643 | (17,634) | 3,244 | 11,598 | | | Non-recurring Events | | Discontinued Operations | (10,128) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,515 | (17,634) | 3,244 | 11,598 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $16,515 | ($17,634) | $3,244 | $11,598 |
|
0.51% Nasdaq 
Income Statement
